Recall of Atovaquone Oral Suspension 750mg/5mL

On May 17, 2023, the U.S. Food and Drug Administration (FDA) announced that Camber Pharmaceuticals, Inc. is voluntarily recalling one lot number of Atovaquone Oral Suspension 750mg/5mL as a Class I Recall due to a potential microbial contamination.

Please note that not all lots are affected, so you may not be affected by this recall. Your health and safety are important to us. If you are currently taking Atovaquone Oral Suspension 750mg/5mL, please call your health care provider to talk about other treatments or medicine that may be appropriate.

For more information, please visit or call Inmar at 1-877-597-0878 (TTY 711), weekdays, 9 a.m. to 5 p.m., Eastern Time (ET). You can also call the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711), weekdays, 8 a.m. to 5 p.m., ET.